Pharmabiz13m
Allowing separate timelines for large units and MSMES may create two categories of manufacturing facilities: Experts
Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] ...
Pharmabiz13m
KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes
KPRDO asks FDA to take action against Swiggy & PharmEasy for drug delivery in 10 minutes: Nandita Vijayasimha, Bengaluru ...
Pharmabiz13m
MP DCA forms team of regulatory officers to assist pharma units in upgrading plants as per revised Schedule M
Peethaambaran Kunnathoor, Chennai Monday, January 13, 2025, 08:00 Hrs [IST] ...
Pharmabiz13m
Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing
Panel asks govt to provide duty concessions, reduced GST rates for growth of medical devices manufacturing: Gireesh Babu, New Delhi Monday, January 13, 2025, 08:00 Hrs [IST] A Par ...
Pharmabiz13m
Exporters concerned over delay in getting relief under Section 43B(h) of IT Act
Exporters concerned over delay in getting relief under Section 43B(h) of IT Act: Shardul Nautiyal, Mumbai Monday, January 13, 2025, 08:00 Hrs [IST] India’s pharmaceutical export ...
Pharmabiz1d
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim and Synaffix B.V. (Synaffix), a Lonza company focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug conjugates (ADCs ...
Pharmabiz1d
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market
Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the Middle East market – both for Gaelic Laboratories and its marketing partners ...
Pharmabiz1d
Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy
Astellas Pharma Inc. announced the US Food and Drug Administration (FDA) accepted the revised supplemental New Drug Application (sNDA) for Izervay (avacincaptad pegol intravitreal solution) for the ...
Pharmabiz1d
Seven research leaders awarded prestigious NIHR award
The NIHR has announced the latest outstanding researchers to become NIHR Research Professors. They will play a key role in undertaking professorial-level research that has a positive impact on the ...
Pharmabiz1d
US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis
Johnson & Johnson announced the nipocalimab Biologics License Application (BLA) received Priority Review designation from the US Food and Drug Administration (FDA) for the treatment of antibody ...
Pharmabiz1d
EU looks at India as best option over China, reflecting potential shifts in trade dynamics
The European Union's preference for India over China in the pharmaceutical sector is rooted in several strategic factors including the access to qualified and skilled workforce. India has a proven ...
Pharmabiz1d
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation
GSK plc, a global biopharma company, announced that the US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s ...